33
Participants
Start Date
December 31, 2011
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
ADX-N05
150 mg once a day for seven days followed by 300 mg once a day for seven days
Placebo
Placebo to match ADX-N05 once a day for 2 consecutive weeks
The Center for Sleep and Wake Disorders, Chevy Chase
SleepMed of South Carolina, Columbia
Neurotrials Research, Inc., Atlanta
Sleep Disorders Center of Georgia, Atlanta
SleepMed of Central Georgia, Macon
Clinical Research Group of St. Petersburg, St. Petersburg
Mercy St. Anne Sleep Disorders Center, Toledo
Sleep Medicine Associates of Texas, Dallas
Future Search Trials of Neurology, Austin
Pulmonary Associates, Phoenix
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY